Search - tctmd.com

Displaying 321 - 340 of 748

Sort: Relevancy | Date

News Daily News

Transradial PCI May Improve Long-term Survival in NSTEMI

Todd Neale

July 17, 2014

News Daily News

STREAM Substudy: Lytic Failure Means Worse Outcomes for Pharmacoinvasively Treated STEMI Patients

July 17, 2014

News Daily News

Long-term Mortality Worse for Black vs White NSTEMI Patients, Linked with Treatment Discrepancies

July 17, 2014

News Daily News

HEAT-PPCI发布：关于直接PCI中肝磷脂较比伐卢定有优势的差异性发现仍然难以理解

Yael L. Maxwell

July 17, 2014

News Daily News

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

Yael L. Maxwell

July 17, 2014

News Daily News

HEAT-PPCI Publicado: El Discrepante Hallazgo de la Superioridad de la Heparina sobre la Bivalirudina en PCI Primarias Sigue Confundiendo

Yael L. Maxwell

July 17, 2014

News Daily News

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

July 10, 2014

News Industry News

BIOTRONIK Announces First Enrollments to BIOFLEX PEACE Registry

July 10, 2014

News Industry News

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

July 07, 2014

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

News Daily News

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

July 03, 2014

News Daily News

EVAR Safer Than Surgery Even in Low-Risk Men

June 27, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Industry News

Study Shows CRT-D Devices with Medtronic AdaptivCRT(TM) Associated with Reduction of Costs of Atrial Fibrillation

June 18, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Daily News

CoreValve Approved for TAVR in High-Risk Patients

June 17, 2014

News Daily News

SYMPLICITY HTN-2: La Denervación Renal es Segura y Eficaz a los 3 Años

Yael L. Maxwell

June 11, 2014

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Yael L. Maxwell

May 23, 2014

Advertisement

Transradial PCI May Improve Long-term Survival in NSTEMI

STREAM Substudy: Lytic Failure Means Worse Outcomes for Pharmacoinvasively Treated STEMI Patients

Long-term Mortality Worse for Black vs White NSTEMI Patients, Linked with Treatment Discrepancies

HEAT-PPCI发布：关于直接PCI中肝磷脂较比伐卢定有优势的差异性发现仍然难以理解

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

HEAT-PPCI Publicado: El Discrepante Hallazgo de la Superioridad de la Heparina sobre la Bivalirudina en PCI Primarias Sigue Confundiendo

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

BIOTRONIK Announces First Enrollments to BIOFLEX PEACE Registry

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

EVAR Safer Than Surgery Even in Low-Risk Men

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Study Shows CRT-D Devices with Medtronic AdaptivCRT(TM) Associated with Reduction of Costs of Atrial Fibrillation

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

CoreValve Approved for TAVR in High-Risk Patients

SYMPLICITY HTN-2: La Denervación Renal es Segura y Eficaz a los 3 Años

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content